搜索临床试验以:lexiscan
总计53个结果
-
University of UtahNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
University of Maryland, BaltimoreNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
University of NebraskaGE Healthcare; Astellas Pharma US, Inc.完全的
-
Rush University Medical Center终止
-
Rush University Medical CenterJohn H. Stroger Hospital完全的患有严重慢性肾脏病的患者正在使用应激剂 Regadenoson 对心脏进行核压力测试进行评估美国
-
University of Alabama at BirminghamAstellas Scientific & Medical Affairs, Inc.完全的
-
VA Office of Research and DevelopmentVA St. Louis Health Care System终止
-
VersitiDana-Farber Cancer Institute; University of Illinois at Chicago; Medical College of Wisconsin; Oregon... 和其他合作者未知
-
Northwestern UniversityAstellas Pharma Global Development, Inc.完全的
-
Medical University of South CarolinaAstellas Pharma US, Inc.完全的
-
Wake Forest University Health SciencesAstellas Pharma US, Inc.终止
-
Timothy M. BatemanSaint Luke's Health System; Saint Luke's Cardiovascular Consultants完全的
-
Timothy M. Bateman, MD完全的
-
Washington University School of MedicineAstellas Pharma US, Inc.完全的
-
Dana-Farber Cancer InstituteJohns Hopkins University; Baylor College of Medicine; Washington University School of Medicine; National... 和其他合作者完全的
-
Astellas Pharma Inc完全的
-
Dipan ShahAstellas Pharma Global Development, Inc.未知
-
St. Louis UniversityAstellas Pharma US, Inc.; University of Florida完全的
-
Astellas Pharma Global Development, Inc.完全的使用单光子发射计算机断层扫描 (SPECT) 进行心肌灌注成像 (MPI) 与单独使用 Regadenoson 相比,在不充分的运动压力测试后评估 Regadenoson 给药的研究 (EXERRT)冠状动脉疾病 (CAD)美国, 秘鲁, 阿根廷, 波多黎各
-
Aiden AbidovAstellas Pharma US, Inc.未知
-
Mayo ClinicAstellas Pharma US, Inc.; University of Nebraska; Lantheus Medical Imaging完全的
-
Dana-Farber Cancer InstituteJohns Hopkins University; Washington University School of Medicine; National Heart, Lung, and... 和其他合作者完全的
-
Astellas Pharma Global Development, Inc.完全的
-
Cardiovascular Imaging TechnologiesAstellas Pharma US, Inc.未知
-
Washington University School of MedicineAstellas Pharma US, Inc.完全的